Literature DB >> 338281

Interindividual differences in the response to oral anticoagulants.

A M Breckenridge.   

Abstract

Mesh：

Substances：

Year:  1977        PMID： 338281     DOI： 10.2165/00003495-197714050-00003

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  35 in total

1.  HEREDITARY TRANSMISSION OF EXCEPTIONAL RESISTANCE TO COUMARIN ANTICOAGULANT DRUGS. THE FIRST REPORTED KINDRED.

Authors:  R A O'REILLY; P M AGGELER; M S HOAG; L S LEONG; M L KROPATKIN
Journal:  N Engl J Med       Date:  1964-10-15       Impact factor: 91.245

2.  THE BIOLOGICAL DISAPPEARANCE RATE OF PROTHROMBIN, FACTORS VII, IX AND X FROM PLASMA IN HYPOTHYROIDISM, HYPERTHYROIDISM, AND DURING FEVER.

Authors:  E A LOELIGER; B VAN DER ESCH; M J MATTERN; H C HEMKER
Journal:  Thromb Diath Haemorrh       Date:  1964-01-01

3.  Dose response and minimal daily requirement for vitamin K in man.

Authors:  P G Frick; G Riedler; H Brögli
Journal:  J Appl Physiol       Date:  1967-09       Impact factor: 3.531

4.  The stereoselective interaction of warfarin and metronidazole in man.

Authors:  R A O'Reilly
Journal:  N Engl J Med       Date:  1976-08-12       Impact factor: 91.245

5.  Kinetics of warfarin absorption in man.

Authors:  A Breckenridge; M Orme
Journal:  Clin Pharmacol Ther       Date:  1973 Nov-Dec       Impact factor: 6.875

6.  Vitamin K in hereditary resistance to oral anticoagulant drugs.

Authors:  R A O'Reilly
Journal:  Am J Physiol       Date:  1971-11

7.  Oral anticoagulants--the totem and the taboo.

Authors:  A Breckenridge
Journal:  Br Med J       Date:  1976-02-21

Review 8.  Pharmacodynamic and pharmacokinetic drug interactions with coumarin anticoagulants.

Authors:  S M MacLeod; E M Sellers
Journal:  Drugs       Date:  1976       Impact factor: 9.546

9.  The physiological disposition of ethyl biscoumacetate (tromexan) in man and a method for its estimation in biological material.

Authors:  B B BRODIE; M WEINER; J J BURNS; G SIMSON; E K YALE
Journal:  J Pharmacol Exp Ther       Date:  1952-12       Impact factor: 4.030

10.  Serum protein binding as a determinant of warfarin body clearance and anticoagulant effect.

Authors:  A Yacobi; J A Udall; G Levy
Journal:  Clin Pharmacol Ther       Date:  1976-05       Impact factor: 6.875
View more
  13 in total

1.  A simple technique for predicting maintenance dosage of warfarin--is it better than empirical dosing?

Authors:  L Ovesen; S Lyduch; P Ott
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

2.  Inter-relationship among individual vitamin K-dependent clotting factors at different levels of anticoagulation.

Authors:  E Chan; L Aarons; M Serlin; A Breckenridge; M Rowland
Journal:  Br J Clin Pharmacol       Date:  1987-11       Impact factor: 4.335

3.  Attitudes to development of drug therapy in Scandinavia.

Authors:  F Sjöqvist; G Boethius
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

4.  Therapeutic control of anticoagulant treatment.

Authors:  B M Duxbury
Journal:  Br Med J (Clin Res Ed)       Date:  1982-03-06

5.  The anticoagulant, antithrombotic and haemorrhagic effect of long-term warfarin on experimental venous and arterial thrombosis in the rat.

Authors:  M MacIomhair; S M Lavelle
Journal:  Ir J Med Sci       Date:  1996 Jul-Sep       Impact factor: 1.568

6.  Glucuronidation of monohydroxylated warfarin metabolites by human liver microsomes and human recombinant UDP-glucuronosyltransferases.

Authors:  Agnieszka Zielinska; Cheryl F Lichti; Stacie Bratton; Neil C Mitchell; Anna Gallus-Zawada; Vi-Huyen Le; Moshe Finel; Grover P Miller; Anna Radominska-Pandya; Jeffery H Moran
Journal:  J Pharmacol Exp Ther       Date:  2007-10-05       Impact factor: 4.030

Review 7.  Clinical pharmacokinetics and pharmacodynamics of warfarin. Understanding the dose-effect relationship.

Authors:  N H Holford
Journal:  Clin Pharmacokinet       Date:  1986 Nov-Dec       Impact factor: 6.447

8.  Warfarin with fluoroquinolones, sulfonamides, or azole antifungals: interactions and the risk of hospitalization for gastrointestinal bleeding.

Authors:  H Schelleman; W B Bilker; C M Brensinger; X Han; S E Kimmel; S Hennessy
Journal:  Clin Pharmacol Ther       Date:  2008-08-06       Impact factor: 6.875

Review 9.  Clinical pharmacokinetics of oral anticoagulants.

Authors:  J G Kelly; K O'Malley
Journal:  Clin Pharmacokinet       Date:  1979 Jan-Feb       Impact factor: 6.447

10.  Dosing algorithms to predict warfarin maintenance dose in Caucasians and African Americans.

Authors:  H Schelleman; J Chen; Z Chen; J Christie; C W Newcomb; C M Brensinger; M Price; A S Whitehead; C Kealey; C F Thorn; F F Samaha; S E Kimmel
Journal:  Clin Pharmacol Ther       Date:  2008-07-02       Impact factor: 6.875
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.